Motley Fool Money cover image

DTC Healthcare with 23andMe CEO Anne Wojcicki

Motley Fool Money

00:00

Innovations in Drug Development Through Genetic Insights

This chapter explores a company's groundbreaking approach to drug development by utilizing genetic health data to identify new therapeutic possibilities. It details their journey from lab insights to successful collaborations with major pharmaceutical firms, all while addressing unmet medical needs.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app